Dr. Dustin Sulak Discusses Acidic Cannabinoids, Ketamine, and Their Therapeutic Benefits at Cannabis Science Conference East 2022

September 16, 2022

Article

Dr. Dustin Sulak of Healer.com and Integr8 Health shares some insights from two talks he gave at Cannabis Science Conference East 2022.

Here, Dr. Dustin Sulak shares some of the key talking points from both of his talks at Cannabis Science Conference East 2022. His first talk in the Medical track was titled "Cannabinoid Acids: Inactive Precursors or Powerful Therapeutics?" and his second talk in the Psychedelics track was titled “Ketamine at Home: An Effective Adjunct to Cannabis?"

View the video for more of the discussion.

Related Content

Beyond THC and CBD: The Therapeutic Potential of Minor Cannabinoids in Cannabis

Scott Mazza

November 12th 2024

Article

Here, Scott Mazza, Founder of Vitality CBD, provides an overview on the potential benefits of minor cannabinoids including cannabinol (CBN) and cannabingerol (CBG).

Rescheduling Cannabis: Are We Entering A New Era?

Lo Friesen

November 8th 2024

Article

This article examines what rescheduling cannabis would involve, the implications for various sectors, and the potential roadblocks that could arise along the way.

Cannabis Research Studies Update: Insights from the Latest Healer Webinar

Erin McEvoy

October 26th 2024

Article

This month’s webinar covered research on cannabis studied as a treatment for rheumatic disorders, menstrual symptoms, eczema, and more.

Differences in Perception of Medical Cannabis Policies Among Chronic Pain Patients and Physicians: Survey Results

Erin McEvoy

October 3rd 2024

Article

Overall, the survey revealed that people with chronic pain supported policies expanding medical cannabis access more than physicians.

Predictions for the Future of Cannabis: A Webinar from the Cannabis Research Center

Erin McEvoy

September 18th 2024

Article

Panelists discussed the impacts of cannabis as a schedule 3 substance on research, legislation, patients, and more.

New Jersey Governor Signs Bill to Regulate Hemp-Derived Cannabinoids

Erin McEvoy

September 13th 2024

Article

The bill regulates the sale and distribution of products containing synthetic THC, though some challenges remain to be resolved.

Related Content

Beyond THC and CBD: The Therapeutic Potential of Minor Cannabinoids in Cannabis

Scott Mazza

November 12th 2024

Article

Here, Scott Mazza, Founder of Vitality CBD, provides an overview on the potential benefits of minor cannabinoids including cannabinol (CBN) and cannabingerol (CBG).

Rescheduling Cannabis: Are We Entering A New Era?

Lo Friesen

November 8th 2024

Article

This article examines what rescheduling cannabis would involve, the implications for various sectors, and the potential roadblocks that could arise along the way.

Cannabis Research Studies Update: Insights from the Latest Healer Webinar

Erin McEvoy

October 26th 2024

Article

This month’s webinar covered research on cannabis studied as a treatment for rheumatic disorders, menstrual symptoms, eczema, and more.

Differences in Perception of Medical Cannabis Policies Among Chronic Pain Patients and Physicians: Survey Results

Erin McEvoy

October 3rd 2024

Article

Overall, the survey revealed that people with chronic pain supported policies expanding medical cannabis access more than physicians.

Predictions for the Future of Cannabis: A Webinar from the Cannabis Research Center

Erin McEvoy

September 18th 2024

Article

Panelists discussed the impacts of cannabis as a schedule 3 substance on research, legislation, patients, and more.

New Jersey Governor Signs Bill to Regulate Hemp-Derived Cannabinoids

Erin McEvoy

September 13th 2024

Article

The bill regulates the sale and distribution of products containing synthetic THC, though some challenges remain to be resolved.